Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.

ABSTRACT:

SUBMITTER: Witte D 

PROVIDER: S-EPMC9021029 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature